Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs
Eschweiler, Simon, Ramírez-Suástegui, Ciro, Li, Yingcong, King, Emma, Chudley, Lindsey, Thomas, Jaya, Wood, Oliver, von Witzleben, Adrian, Jeffrey, Danielle, McCann, Katy, Simon, Hayley, Mondal, Monalisa, Wang, Alice, Dicker, Martina, Lopez-Guadamillas, Elena, Chou, Ting-Fang, Dobbs, Nicola A, Essame, Louisa, Acton, Gary, Kelly, Fiona, Halbert, Gavin, Sacco, Joseph J, Schache, Andrew Graeme, Shaw, Richard, McCaul, James Anthony, Paterson, Claire, Davies, Joseph H, Brennan, Peter A, Singh, Rabindra P, Loadman, Paul M, Wilson, William, Hackshaw, Allan, Seumois, Gregory, Okkenhaug, Klaus, Thomas, Gareth J, Jones, Terry M, Ay, Ferhat, Friberg, Greg, Kronenberg, Mitchell, Vanhaesebroeck, Bart, Vijayanand, Pandurangan, Ottensmeier, Christian H
Published in Nature (London) (26.05.2022)
Published in Nature (London) (26.05.2022)
Get full text
Journal Article
A randomised, double-blind, placebo-controlled phase IIa trial of AMG319 given orally as neoadjuvant therapy in patients with human papillomavirus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC)
Ottensmeier, Christian H.H, Jones, Terry, Sacco, Joseph J, McCaul, James Anthony, Brennan, Peter, Paterson, Claire, Schache, Andrew Graeme, Shaw, Richard, Singh, Rabindra P, Davies, Joseph H., Chudley, Lindsey, Jeffrey, Danielle, Thomas, Gareth, Loadman, Paul, Dobbs, Nicola A, Essame, Louisa, Acton, Gary, Katugampola, Sidath, Vanhaesebroeck, Bart, King, Emma
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article